Authur Mendolia, Co-Founder of Cambrex, Dies
Stephanie LaFiura, Investor Relations Associate
East Rutherford, NJ - Cambrex Corporation (NYSE: CBM, "Cambrex") announces that Arthur Mendolia, co-founder and retired Chairman, died October 19th in Wilmington Delaware, at the age of ninety.
Cambrex's origins began in 1981 as a chemical company through the vision of two men, Arthur Mendolia and Cyril Baldwin. Mr. Mendolia and Mr. Baldwin ambitiously bought a castor oil and polyurethane production company and named it CasChem, Inc. Cosan, a biocide company, was purchased in 1985 and additional acquisitions followed in subsequent years. In 1987, the Company changed its name to Cambrex, comprised of the initials of the co-founders (CAMB). The Company went public the same year and subsequently listed on the New York Stock Exchange under the symbol CBM. Through internal growth and acquisitions, Mr. Mendolia and Mr. Baldwin grew the Company in the chemical field, and in the 1990's entered the life sciences arena. Cambrex has recently divested its chemical and biotechnology businesses, but remains in the human health industry. Mr. Mendolia served as its Chairman and Chief Executive Officer of the Company from 1981 to 1987, and remained a Director until his retirement in 1995.
Mr. James A. Mack, Chairman, President and CEO, said, "We are saddened by the loss of our co-founder, Art Mendolia. His vision and foresight in the specialty chemicals business gave Cambrex its solid beginnings. Our sincere sympathies go to his wife Edythe and the other members of his family."
Arthur Mendolia served as a Director on the boards of The Bank of New York and UNUM Corporation and was a Trustee of the Delaware Art Museum.
Mr. Mendolia received a B.S. in Chemical Engineering in 1941 from Case Institute of Technology. He remained an active and supportive alum, served on the Board of Governors, and in 1979 accepted the Case Alumni Association Gold Medal Award, its highest honor for an alumnus.
Joining the DuPont Company in 1941 as a research engineer, Mr. Mendolia retired in 1973 as Vice President and General Manager of the Explosives Department. From 1973 to 1975, he served as Assistant Secretary of Defense under Presidents Nixon and Ford.
Mr. Mendolia returned to the private sector as President of Halcon International in New York City and later as Chairman of Oxirane International in Princeton, New Jersey. Mr. Mendolia and Mr. Baldwin received the Winthrop-Sears Award for Entrepreneurship in 1990.
He is survived by his wife Edythe, two daughters, four grandchildren, and two-great-grandchildren.
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.